December 28, 2006
Specialist in Prevention and Treatment of Ovarian Cancer Joins Neag
Cancer Center
FARMINGTON, CONN. – Molly Brewer, M.D., has been appointed the
director of gynecologic oncology at the Neag Comprehensive Cancer Center
at the University of Connecticut Health Center. Dr. Brewer, who
specializes in the prevention and treatment of ovarian cancer, sees
patients at the Farmington campus.
A Farmington resident, Dr Brewer comes to the Health Center from the
Arizona Cancer Center at the University of Arizona in Tucson, where she
was the director of the cancer center’s gynecologic oncology division.
Prior to that, she was the division director of obstetrics and
gynecology at the University of Texas-Houston Medical School.
Dr. Brewer earned her medical degree from the College of Medicine at the
State University of New York at Syracuse and completed her residency at
Oregon Health Sciences in Portland. She held fellowships at Memorial
Sloan-Kettering Cancer Center in New York City and at the M.D. Anderson
Cancer Center in Houston. She also holds a master’s degree in
statistical analysis and clinical research design from the University of
Michigan School of Public Health in Ann Arbor. She is board certified in
obstetrics and gynecology and gynecologic oncology.
Download a high resolution photo of Dr. Brewer at:
http://www.uchc.edu/ocomm/images/images_news/brewer.jpg.
The Carole and Ray Neag Comprehensive Cancer Center provides a full spectrum of cancer services, from education and prevention strategies to early detection services, innovative,
state-of-the-art treatments, reconstructive surgery, rehabilitation and support services. In addition, patients at the Neag Comprehensive Cancer Center can participate in a range of clinical
trials and research studies. Services are provided in a convenient location at the UConn Health Center campus in Farmington. For more information, visit
http://cancer.uchc.edu.
|
We
offer a full range of community programs.
A quarterly publication designed for medical professionals who are involved in cancer research or care of patients with cancer.
